May 21, 2013
Higher rates of obesity and higher BMIs observed in men with remitted ADHD versus men with no ADHD history.
May 15, 2013
Xofigo has been approved three months ahead of schedule to treat men with metastatic castration-resistant prostate cancer.
May 07, 2013
There is a direct correlation between testosterone and metabolic syndrome, mental function, libido, erectile dysfunction, bone density, and overall energy.
March 06, 2013
Primary-care practitioner beliefs about prostate-cancer screening account for much of the variability in the use of an informed-decision-making process.
February 11, 2013
Regular, moderate exercise was associated with decreased prostate cancer risk in white, but not black, men.
December 11, 2012
The FDA has expanded the indication for abiraterone acetate to include treating late-stage castration-resistant prostate cancer before the administration of chemotherapy.
October 22, 2012
American boys are 6 months to 2 years younger at puberty onset today compared with studies dating back to the 1930s.
October 02, 2012
Does varicocele grade correlate with impotency level?
October 01, 2012
A patient has elevated creatine and fasciculations. Could an electrolyte imbalance be the cause?
September 25, 2012
Excess fat around the gluteal region can make performing digital rectal exams in obese patients difficult. How can this challenge be overcome?
September 24, 2012
What treatment do you recommend for scrotal dermatitis?
September 13, 2012
Choline C 11 Injection, a PET scan imaging agent, is now available for men with elevated PSA levels after earlier treatment for prostate cancer.
September 04, 2012
Stinging nettle has been used to treat arthritis and other inflammatory conditions since the 10th century.
August 30, 2012
Moderate chocolate consumption lowered the risk for any type of stroke 17% to 19%.
August 28, 2012
Clinicians should check how well patients are responding to testosterone replacement therapy every three to four months during the first year.
August 22, 2012
Estimates project that decreases in male circumcision rates would likely correlate with greater prevalence of sexually transmitted diseases and medical costs in both men and women.
August 14, 2012
A lump, enlarging scrotum or pain can conjure up images of testicular cancer, but other conditions involving the scrotal content are possible.
August 06, 2012
The FDA has approved ziv-aflibercept (Zaltrap, Sanofi-Aventis) in combination with a FOLFIRI regimen for adults with advanced metastatic colorectal cancer.
July 30, 2012
Men typically seek treatment after melanoma has already progressed to later stages, accounting for higher mortally rates compared with women.
June 26, 2012
The Prostate Health Index is a non-invasive blood test that is 2.5-times more specific in detecting prostate cancer than prostate-specific antigen in patients with PSA values in the 4-10 ng/mL range.
Based on the evidence, the U.S. Preventive Services Task Force gave a grade D recommendation against PSA-based screening for men in the general U.S. population, regardless of age.
Only 50% of clinicians surveyed agree with U.S. Preventive Services Task Force recommendations not to perform routine PSA screening.
April 27, 2012
Many clinicians find it difficult to determine when it's appropriate to stop screening patients for prostate cancer.
A 69-year-old man with multiple health conditions develops gynecomastia after hemodialysis. Are the two related?
April 01, 2012
Men taking daily long-acting opioids were nearly five times more likely to become hypogonadal than were men on short-acting opioids.
March 16, 2012
Extended follow-up data from the European Randomized Study of Screening for Prostate Cancer shows screening reduced risk of death from prostate cancer, but not all-cause mortality.
March 07, 2012
The American College of Physicians recommends clinicians begin screening average-risk individuals for colorectal cancer at age 50 years.
February 25, 2012
Early-onset androgenetic alopecia, or male-pattern baldness, may be a marker of urinary symptoms associated with an enlarged prostate, data indicate.
Although low serum testosterone is associated with increased adiposity, an adverse metabolic risk profile, and atherosclerosis, few studies have shown a protective link between endogenous testosterone and cardiovascular events, until recently.
Two studies offer data about the effects if vitamin E and saw palmetto on the prostate.
